| Product Code: ETC6099004 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Angola Molecular Point of Care Testing (using NAAT) Market Overview |
3.1 Angola Country Macro Economic Indicators |
3.2 Angola Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, 2021 & 2031F |
3.3 Angola Molecular Point of Care Testing (using NAAT) Market - Industry Life Cycle |
3.4 Angola Molecular Point of Care Testing (using NAAT) Market - Porter's Five Forces |
3.5 Angola Molecular Point of Care Testing (using NAAT) Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Angola Molecular Point of Care Testing (using NAAT) Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Angola Molecular Point of Care Testing (using NAAT) Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 Angola Molecular Point of Care Testing (using NAAT) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Angola |
4.2.2 Growing awareness about the benefits of molecular point of care testing (using NAAT) in accurate and rapid disease diagnosis |
4.2.3 Government initiatives to improve healthcare infrastructure and access to advanced diagnostic technologies in Angola |
4.3 Market Restraints |
4.3.1 High cost associated with molecular point of care testing (using NAAT) technologies |
4.3.2 Limited availability of skilled healthcare professionals to operate and interpret test results |
4.3.3 Challenges related to maintaining and servicing complex diagnostic equipment in remote areas of Angola |
5 Angola Molecular Point of Care Testing (using NAAT) Market Trends |
6 Angola Molecular Point of Care Testing (using NAAT) Market, By Types |
6.1 Angola Molecular Point of Care Testing (using NAAT) Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Angola Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Angola Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.4 Angola Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.5 Angola Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Reagents, 2021- 2031F |
6.2 Angola Molecular Point of Care Testing (using NAAT) Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Angola Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Respiratory Infections Testing, 2021- 2031F |
6.2.3 Angola Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Sexually Transmitted Infection (STI) Testing, 2021- 2031F |
6.2.4 Angola Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Gastrointestinal Tract Infections Testing, 2021- 2031F |
6.2.5 Angola Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Angola Molecular Point of Care Testing (using NAAT) Market, By End users |
6.3.1 Overview and Analysis |
6.3.2 Angola Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Laboratories, 2021- 2031F |
6.3.3 Angola Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.4 Angola Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.5 Angola Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Ambulatory Centers, 2021- 2031F |
6.3.6 Angola Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Others, 2021- 2031F |
7 Angola Molecular Point of Care Testing (using NAAT) Market Import-Export Trade Statistics |
7.1 Angola Molecular Point of Care Testing (using NAAT) Market Export to Major Countries |
7.2 Angola Molecular Point of Care Testing (using NAAT) Market Imports from Major Countries |
8 Angola Molecular Point of Care Testing (using NAAT) Market Key Performance Indicators |
8.1 Average turnaround time for test results |
8.2 Number of training programs conducted for healthcare professionals on molecular point of care testing (using NAAT) |
8.3 Percentage increase in the adoption of molecular point of care testing (using NAAT) technologies in healthcare facilities |
8.4 Rate of compliance with quality standards and regulations for molecular point of care testing (using NAAT) in Angola |
8.5 Number of partnerships and collaborations between diagnostic companies and healthcare facilities for the promotion of molecular point of care testing in Angola |
9 Angola Molecular Point of Care Testing (using NAAT) Market - Opportunity Assessment |
9.1 Angola Molecular Point of Care Testing (using NAAT) Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Angola Molecular Point of Care Testing (using NAAT) Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Angola Molecular Point of Care Testing (using NAAT) Market Opportunity Assessment, By End users, 2021 & 2031F |
10 Angola Molecular Point of Care Testing (using NAAT) Market - Competitive Landscape |
10.1 Angola Molecular Point of Care Testing (using NAAT) Market Revenue Share, By Companies, 2024 |
10.2 Angola Molecular Point of Care Testing (using NAAT) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here